GL1X · GenesisL1 explorer

Research workbench

Vim-2_1DI-triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases

Analyse Vim-2_1DI-triazole inhibitors with promising inhibitor effects against… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6TMB
Type
protein
Length
460 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase class B vim-2
UniProt
Q9K2N0
Ligands
9OB, ZN, CL, OH, IOD
Pockets
1 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase class B vim-2protein23028% helix, 29% strandQ9K2N0

Ligands and binding sites

  • 9OB · ~{N}-[[5-[[(phenylmethyl)amino]methyl]-1~{H}-1,2,3-triazol-4-yl]methyl]benzenesulfonamide · ligand · chains A, B
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • CL · Chloride ion · ion · 4 copies · chains A, B
  • OH · Hydroxide ion · ion · 2 copies · chains A, B
  • IOD · Iodide ion · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15620.750.8253ZN, OH, 9OB, IOD

Interfaces

1 interface between chains.

  • A–B · 565 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 6TMB · VIM-2_1di-Triazole inhibitors with promising inhibitor effects against antibiotic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.